BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Adipose tissue
,
Hematopoietic cell
,
Valproic acid
,
rs2230926
,
IL1A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Dipyridamole
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
SCD
PDE10A
CYP51A1
PPP2CA
PCLO
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
heterocyclic compound binding
regulation of nitrogen compound metabolic process
organic cyclic compound binding
GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Liver tissues from rats after treatment with different compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Explore Curated Studies Results
Literature
Most Relevant Literature
Dipyridamole in antithrombotic treatment.
Isolation and characterisation of degradant impurities in dipyridamole formulation.
Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine…
Dipyridamole decreases inflammatory metalloproteinase-9 expression and release by human monocytes.
Novel formulations of dipyridamole with microenvironmental pH-modifiers for improved dissolution and…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Dipyridamole for Immune Activation in HIV
The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)
Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19
Clinical Trial of Dipyridamole in Schizophrenia
Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ